台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國光生

(4142)
可現股當沖
  • 股價
    20.95
  • 漲跌
    ▲1.05
  • 漲幅
    +5.28%
  • 成交量
    3,432
  • 產業
    上市 生技醫療類股▲1.34%
  • 633人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
國光生 (4142)籌碼相關-元大-復北 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-復北 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/26120.8000.0020.9511,0280.10%
2024/12/190.219.3600.0019.300.29710.03%
2024/12/170.119.8000.0019.650.19640.01%
2024/12/160.119.8000.0019.950.19550.01%
2024/12/130.620.2000.0019.900.69410.06%
2024/12/121.320.9500.0020.701.39060.14%
2024/12/11121.30221.1521.25-1901-0.11%
2024/11/282.221.2000.0021.202.28650.25%
2024/11/270.121.60121.5021.30-0.9852-0.11%
2024/11/263.121.7000.0021.703.18470.37%
2024/11/120.323.0500.0022.650.36070.05%
2024/11/111.123.7900.0023.601.16000.18%
2024/11/07124.3000.0024.3515990.17%
2024/11/04124.0000.0024.1016230.16%
2024/10/17325.7000.0025.6538530.35%
2024/10/07127.0500.0027.0018890.11%
2024/09/27227.2000.0027.2029900.20%
2024/08/2100.00128.9028.95-11,237-0.08%
2024/08/1900.00128.8028.70-11,228-0.08%
2024/08/06125.00125.5525.3501,2010.00%
2024/08/050.125.1000.0025.350.11,1900.01%
2024/08/02127.8000.0027.7511,1660.09%
2024/07/19230.30128.8528.8511,0990.09%
2024/07/1000.00229.0028.60-21,175-0.17%
2024/07/0900.00228.3028.20-21,166-0.17%
2024/07/0800.00328.9029.05-31,149-0.26%
2024/07/01228.7000.0028.6521,0480.19%
2024/06/2500.00128.0528.10-11,002-0.10%
2024/06/11128.00527.8027.60-4852-0.47%
2024/05/3000.00427.4027.30-4888-0.45%
2024/05/2300.00228.2527.90-2934-0.21%
2024/05/2200.00828.2128.20-8938-0.85%
2024/05/06528.30228.3028.2031,1150.27%
2024/04/2900.00127.3027.55-11,099-0.09%
2024/04/24127.2500.0027.2011,0960.09%
2024/04/18729.08129.2528.5061,0730.56%
2024/04/160.125.5500.0025.300.19350.01%
2024/04/02026.9000.0026.6009450.00%
2024/03/25126.6500.0026.7519910.10%
2024/03/200.126.4000.0026.650.11,0250.01%
2024/03/180.126.6000.0026.600.11,0270.01%
2024/03/140.227.354027.0826.90-39.81,045-3.81%
2024/03/131.127.7700.0027.801.11,0260.11%
2024/03/080.128.2000.0028.150.11,0400.01%
2024/03/070.228.50628.1228.40-5.81,071-0.54%
2024/03/040.228.90128.6528.70-0.81,094-0.07%
2024/03/011.129.2000.0029.201.11,1150.10%
2024/02/29229.4500.0029.4021,2260.16%
2024/02/27129.7500.0029.6511,2210.08%
2024/02/20230.2300.0030.2021,2120.16%
2024/02/15129.9000.0029.6511,1400.09%
2024/02/0200.00130.3030.05-11,049-0.10%
2024/01/29031.3300.0031.1001,0410.00%
2024/01/23131.2500.0031.1011,0350.10%
2024/01/1700.002831.4531.10-281,036-2.70%
2024/01/1200.00132.1032.10-11,017-0.10%
2024/01/1100.00132.3532.10-11,018-0.10%
2024/01/1000.00132.6532.70-11,012-0.10%
2024/01/05133.2000.0033.1511,0150.10%
2024/01/031033.15133.3533.0091,0220.88%
2024/01/0200.00133.1033.10-1997-0.10%
2023/12/2900.00233.2033.15-21,000-0.20%
2023/12/28233.15133.1033.1011,0010.10%
國光生財報/前三季稅後淨損1.94億元 每股淨損0.46元UDN聯合新聞網-2024/11/13
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
國光生 相關文章